SCHEMBL26106963

SCHEMBL26106963

CC(C=O)=CN1CC2(CC=C(c3c(-c4ccc(Oc5ncccn5)cc4)c4c(N)ncnc4n3C)CC2)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 15/20 0.37
▸ BLK P51451 2/20 0.37
▸ EGFR P00533 1/20 0.37
▸ ERBB2 P04626 1/20 0.37
▸ RET P07949 1/20 0.37
▸ PDGFRB P09619 1/20 0.37
▸ FLT3 P36888 1/20 0.37
▸ TEC P42680 1/20 0.37
▸ TXK P42681 1/20 0.37
▸ BMX P51813 1/20 0.37
▸ ITK Q08881 1/20 0.37
▸ ERBB4 Q15303 1/20 0.37
▸ LCK P06239 4/20 0.35
▸ KDR P35968 4/20 0.35
▸ TEK Q02763 4/20 0.35
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ FGFR1 P11362 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ FGFR2 P21802 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26108768 0.88 BTK (0.36) BTKBLKEGFRERBB2RET
SCHEMBL26107761 0.85 BTK (0.35) BTKBLKEGFRERBB2RET
SCHEMBL26587204 0.85 CYP3A4 (0.40) BTKBLKEGFRERBB2RET
SCHEMBL26587174 0.85 BTK (0.47) BTKBLKEGFRERBB2RET
SCHEMBL26106734 0.84 LCK (0.38) BTKBLKEGFRERBB2RET
SCHEMBL26109060 0.83 BTK (0.35) BTKBLKEGFRERBB2RET
SCHEMBL26107050 0.83 LCK (0.40) BTKBLKEGFRERBB2RET
SCHEMBL30582573 0.83 SRC (0.40) BTKBLKEGFRERBB2RET
SCHEMBL30582498 0.83 BTK (0.50) BTKBLKEGFRERBB2RET
SCHEMBL26105368 0.83 SRC (0.40) BTKBLKEGFRERBB2RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO claimed
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO disclosed
Send feedback